Expression of angiotensin converting enzyme 2 in patients with oral squamous cell carcinoma
Background: Oral squamous cell carcinoma (OSCC), being a multifactorial cancer, is significantly higher in South Asian countries and only 70 % of the cases are reported only in its advanced stages. As a component of the renin-angiotensin system (RAS), Angiotensin-Converting Enzyme 2 (ACE2) has been...
Saved in:
Main Authors: | Shivani Sivasakthivel, Pratibha Ramani, Selvaraj Jayaraman |
---|---|
Format: | Article |
Language: | English |
Published: |
Elsevier
2024-06-01
|
Series: | Oral Oncology Reports |
Subjects: | |
Online Access: | http://www.sciencedirect.com/science/article/pii/S2772906024003224 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Effect of angiotensin-converting enzyme inhibitors versus that of angiotensin receptor blockers on survival in patients undergoing hemodialysis: a nationwide observational cohort study
by: Seok Hui Kang, et al.
Published: (2024-12-01) -
Choosing the Right Angiotensin Converting Enzyme Inhibitors; Gender –Specific Approach
by: Neena Elsa Varghese, et al.
Published: (2024-12-01) -
An Angiotensin-converting Enzyme Inhibition Activity by Various Natural Approaches: A Statistic Review
by: Rupal K. Chhaniyara, et al.
Published: (2024-01-01) -
Angiotensin I converting enzyme (ACE) inhibitory activity and antihypertensive effects of rice peptides
by: Jingjing Dong, et al.
Published: (2022-11-01) -
Retrospective evaluation of risk factors for worsening renal function after angiotensin‐converting enzyme inhibitor treatment in dogs
by: Yelim Lee, et al.
Published: (2025-01-01)